Clinical factors associated with Guillain-Barre syndrome following surgery

被引:27
|
作者
Hocker, Sara [1 ]
Nagarajan, Elanagan [1 ,3 ]
Rubin, Mark [2 ]
Wijdicks, Eelco F. M. [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Northshore Univ Hlth Syst, Dept Neurol, Glenview, IL USA
[3] Univ Missouri, Dept Neurol, Columbia, MO 65211 USA
关键词
D O I
10.1212/CPJ.0000000000000451
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background We sought to identify clinical associations and potential triggers of Guillain-Barre syndrome (GBS) within 6 weeks of surgery. Methods We retrospectively reviewed consecutive patients diagnosed with GBS within 6 weeks of a surgery between January 1995 and June 2014 at Mayo Clinic. Postsurgical GBS was defined as symptom onset within 6 weeks of surgery. Patients with postsurgical GBS were compared with patients who did not have a surgery prior to GBS onset to determine differences between groups. Results A total of 208 patients with GBS, median age 55 years (interquartile range [IQR] 41-68), were included. Nineteen patients (9.1%) developed postsurgical GBS. Median duration from the surgery to onset of first GBS symptom was 15 days (IQR 9-37). The main types of surgeries preceding GBS were gastrointestinal, orthopedic, and cardiac. General anesthesia was used in 18 (95%) and conscious sedation in 1 (5%) patient. Among the 19 patients with postsurgical GBS, 11 (57.9%) had a known diagnosis of malignancy. Autoimmune conditions were present in 5 (26.3%) patients. Postoperative infection was found in 4 (21%) patients. On univariate analysis, the factors that showed an association with postsurgical GBS were age (p = 0.02), malignancy (p = 0.0004), active malignancy (p = 0.03), preexisting autoimmune disorder (p = 0.02), and infection (p = 0.0001). On multivariate analysis, only active malignancy (0.03) remained associated. Conclusions Surgery antedated GBS in 9.1% of patients. Postsurgical GBS was more common in patients with an active malignancy. A prospective study is needed to determine whether active malignancy represents an independent risk factor for the development of postsurgical GBS.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 50 条
  • [31] THE GUILLAIN-BARRE SYNDROME
    DELEHOCZKY, T
    LANCET, 1949, 257 (DEC17): : 1153 - 1153
  • [32] GUILLAIN-BARRE SYNDROME
    不详
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 197 (08): : 655 - &
  • [33] Guillain-Barre syndrome
    Burns, Ted M.
    SEMINARS IN NEUROLOGY, 2008, 28 (02) : 152 - 167
  • [34] Guillain-Barre syndrome
    Shahrizaila, Nortina
    Lehmann, Helmar C.
    Kuwabara, Satoshi
    LANCET, 2021, 397 (10280): : 1214 - 1228
  • [35] Guillain-Barre syndrome
    Ho, T
    Griffin, J
    CURRENT OPINION IN NEUROLOGY, 1999, 12 (04) : 389 - 394
  • [36] Guillain-Barre Syndrome
    Paterson, Beverley J.
    Durrheim, David N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (10): : 973 - 973
  • [37] Guillain-Barre syndrome
    Hughes, RAC
    Cornblath, DR
    LANCET, 2005, 366 (9497): : 1653 - 1666
  • [38] GUILLAIN-BARRE SYNDROME
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1951, 147 (11): : 1091 - 1091
  • [39] GUILLAIN-BARRE SYNDROME
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1957, 2 (JUL13): : 115 - 115
  • [40] Guillain-Barre Syndrome
    Malek, Elia
    Salameh, Johnny
    SEMINARS IN NEUROLOGY, 2019, 39 (05) : 589 - 595